FI963467A - Tiatsolidiinidionijohdannaisia veren liikasokerisuuden vastaisina aineina - Google Patents
Tiatsolidiinidionijohdannaisia veren liikasokerisuuden vastaisina aineina Download PDFInfo
- Publication number
- FI963467A FI963467A FI963467A FI963467A FI963467A FI 963467 A FI963467 A FI 963467A FI 963467 A FI963467 A FI 963467A FI 963467 A FI963467 A FI 963467A FI 963467 A FI963467 A FI 963467A
- Authority
- FI
- Finland
- Prior art keywords
- substituted phenyl
- pyridinyl
- phenyl
- diones
- ynyl
- Prior art date
Links
- 230000002058 anti-hyperglycaemic effect Effects 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 11
- -1 2-pyridinyl Chemical group 0.000 abstract 8
- 150000001473 2,4-thiazolidinediones Chemical class 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229920001774 Perfluoroether Chemical group 0.000 abstract 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000003345 hyperglycaemic effect Effects 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20798094A | 1994-03-08 | 1994-03-08 | |
| PCT/US1995/001782 WO1995024400A1 (en) | 1994-03-08 | 1995-02-08 | Thiazolidinedione derivatives as anti-hyperglycemic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI963467A true FI963467A (fi) | 1996-09-04 |
| FI963467A0 FI963467A0 (fi) | 1996-09-04 |
Family
ID=22772754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI963467A FI963467A0 (fi) | 1994-03-08 | 1996-09-04 | Tiatsolidiinidionijohdannaisia veren liikasokerisuuden vastaisina aineina |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5605918A (fi) |
| EP (1) | EP0749430B1 (fi) |
| JP (1) | JPH09509963A (fi) |
| KR (1) | KR100342761B1 (fi) |
| AT (1) | ATE183743T1 (fi) |
| AU (1) | AU679626B2 (fi) |
| BR (1) | BR9507014A (fi) |
| CA (1) | CA2184739A1 (fi) |
| CZ (1) | CZ284592B6 (fi) |
| DE (1) | DE69511683T2 (fi) |
| DK (1) | DK0749430T3 (fi) |
| ES (1) | ES2135711T4 (fi) |
| FI (1) | FI963467A0 (fi) |
| GR (1) | GR3031496T3 (fi) |
| HU (1) | HUT76482A (fi) |
| IL (1) | IL112738A (fi) |
| NZ (1) | NZ282143A (fi) |
| RU (1) | RU2126395C1 (fi) |
| SG (1) | SG52318A1 (fi) |
| SK (1) | SK280914B6 (fi) |
| TW (1) | TW300222B (fi) |
| UA (1) | UA45333C2 (fi) |
| WO (1) | WO1995024400A1 (fi) |
| ZA (1) | ZA951847B (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040488A1 (en) * | 1997-03-12 | 1998-09-17 | Smithkline Beecham Corporation | Anti-alphabeta3 humanized monoclonal antibodies |
| WO2003018011A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 5-(substituted)-5-(substitutedsulfonyl or sulfanyl)thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| US6605628B1 (en) | 2001-08-24 | 2003-08-12 | Wyeth Holdings Corporation | Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase |
| WO2003018554A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| WO2003018135A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | Method of using 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase |
| AU2010278777B2 (en) | 2009-07-31 | 2015-05-07 | Global Alliance For Tb Drug Development | Nitroimidazooxazines and their uses in anti-tubercular therapy |
| US9198913B2 (en) | 2009-07-31 | 2015-12-01 | Global Alliance For Tb Drug Development | Nitroimidazooxazines and their uses in anti-tubercular therapy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58118577A (ja) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| US4738972A (en) * | 1985-05-21 | 1988-04-19 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
| US4743611A (en) * | 1986-07-02 | 1988-05-10 | American Home Products Corp. | Naphthalenylsulfonylimidazolidinediones and their thioxo analogs useful as aldose reductase inhibitors |
| US5068342A (en) * | 1989-10-27 | 1991-11-26 | American Home Products Corporation | 5-[(1- and 2-naphthalenyl)thio and sulfonyl]-2,4-thiazolidinediones and derivatives thereof |
| US4997948A (en) * | 1989-10-27 | 1991-03-05 | American Home Products | 5-[(1- and 2-naphthalenyl) sulfonyl]-2,4-thiazolidinediones and derivatives thereof |
| TW420669B (en) * | 1994-03-28 | 2001-02-01 | Nissan Chemical Ind Ltd | Pyridine type thiazolidines |
-
1995
- 1995-02-08 DK DK95911696T patent/DK0749430T3/da active
- 1995-02-08 HU HU9602442A patent/HUT76482A/hu unknown
- 1995-02-08 UA UA96103817A patent/UA45333C2/uk unknown
- 1995-02-08 AU AU19168/95A patent/AU679626B2/en not_active Ceased
- 1995-02-08 CA CA002184739A patent/CA2184739A1/en not_active Abandoned
- 1995-02-08 NZ NZ282143A patent/NZ282143A/en unknown
- 1995-02-08 EP EP95911696A patent/EP0749430B1/en not_active Expired - Lifetime
- 1995-02-08 SG SG1996002718A patent/SG52318A1/en unknown
- 1995-02-08 WO PCT/US1995/001782 patent/WO1995024400A1/en active IP Right Grant
- 1995-02-08 BR BR9507014A patent/BR9507014A/pt not_active IP Right Cessation
- 1995-02-08 KR KR1019960705020A patent/KR100342761B1/ko not_active IP Right Cessation
- 1995-02-08 JP JP7523463A patent/JPH09509963A/ja not_active Withdrawn
- 1995-02-08 CZ CZ962594A patent/CZ284592B6/cs not_active IP Right Cessation
- 1995-02-08 RU RU96120159A patent/RU2126395C1/ru active
- 1995-02-08 DE DE69511683T patent/DE69511683T2/de not_active Expired - Fee Related
- 1995-02-08 ES ES95911696T patent/ES2135711T4/es not_active Expired - Lifetime
- 1995-02-08 AT AT95911696T patent/ATE183743T1/de not_active IP Right Cessation
- 1995-02-08 SK SK1133-96A patent/SK280914B6/sk unknown
- 1995-02-22 TW TW084101622A patent/TW300222B/zh active
- 1995-02-22 IL IL11273895A patent/IL112738A/xx not_active IP Right Cessation
- 1995-03-06 ZA ZA951847A patent/ZA951847B/xx unknown
- 1995-05-24 US US08/448,851 patent/US5605918A/en not_active Expired - Lifetime
- 1995-05-24 US US08/449,063 patent/US5574051A/en not_active Expired - Lifetime
-
1996
- 1996-09-04 FI FI963467A patent/FI963467A0/fi unknown
-
1999
- 1999-10-11 GR GR990402589T patent/GR3031496T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL112738A (en) | 1999-09-22 |
| KR970701704A (ko) | 1997-04-12 |
| SG52318A1 (en) | 1998-09-28 |
| CA2184739A1 (en) | 1995-09-14 |
| GR3031496T3 (en) | 2000-01-31 |
| CZ259496A3 (en) | 1997-07-16 |
| AU679626B2 (en) | 1997-07-03 |
| TW300222B (fi) | 1997-03-11 |
| FI963467A0 (fi) | 1996-09-04 |
| RU2126395C1 (ru) | 1999-02-20 |
| ATE183743T1 (de) | 1999-09-15 |
| EP0749430B1 (en) | 1999-08-25 |
| IL112738A0 (en) | 1995-05-26 |
| ES2135711T3 (es) | 1999-11-01 |
| KR100342761B1 (ko) | 2002-12-06 |
| CZ284592B6 (cs) | 1999-01-13 |
| US5605918A (en) | 1997-02-25 |
| MX9603865A (es) | 1997-07-31 |
| HUT76482A (en) | 1997-09-29 |
| DE69511683T2 (de) | 2000-03-02 |
| EP0749430A1 (en) | 1996-12-27 |
| SK113396A3 (en) | 1997-03-05 |
| UA45333C2 (uk) | 2002-04-15 |
| US5574051A (en) | 1996-11-12 |
| ES2135711T4 (es) | 2000-01-01 |
| ZA951847B (en) | 1996-09-06 |
| BR9507014A (pt) | 1997-09-09 |
| HU9602442D0 (en) | 1996-11-28 |
| AU1916895A (en) | 1995-09-25 |
| JPH09509963A (ja) | 1997-10-07 |
| WO1995024400A1 (en) | 1995-09-14 |
| NZ282143A (en) | 1997-12-19 |
| SK280914B6 (sk) | 2000-09-12 |
| DK0749430T3 (da) | 2000-02-07 |
| DE69511683D1 (de) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU743411B2 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
| KR100204433B1 (ko) | 4-아미노피리미딘 유도체 | |
| RU2312106C2 (ru) | Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar | |
| PE20081532A1 (es) | Compuestos novedosos | |
| KR890005095A (ko) | 신규 화합물들 | |
| RU92004381A (ru) | Производные 2-замещенного сахарина как ингибиторы протеолитических ферментов | |
| KR960017648A (ko) | 옥사졸리딘디온 유도체, 그의 제법 및 용도 | |
| CA2486399A1 (en) | Calcium receptor modulating agents | |
| KR920019784A (ko) | 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 | |
| EP2383263A2 (en) | Novel thiazolidinedione derivative and use thereof | |
| PE20040987A1 (es) | Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf) | |
| KR940014392A (ko) | 티아졸리딘디온 유도체, 그의 제조방법 및 용도 | |
| RU2367659C2 (ru) | Гетероарильные производные в качестве активаторов рецепторов, активируемых пролифераторами пероксисом (ppar) | |
| KR890014534A (ko) | 혈당 감소제로서 티아졸리딘디온 유도체 | |
| FI963467A (fi) | Tiatsolidiinidionijohdannaisia veren liikasokerisuuden vastaisina aineina | |
| PL166269B1 (pl) | Sposób wytwarzania nowych farmakologicznie aktywnych pochodnych katecholul PL PL PL PL PL | |
| DE60128239D1 (de) | Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten | |
| KR100608416B1 (ko) | 2-(ｎ-시아노이미노)티아졸리딘-4-온 유도체 | |
| KR880003920A (ko) | 피리다지논 유도체 | |
| KR960704853A (ko) | 피리다지논 유도체 또는 그의 염, 그의 제조 방법 및 그를 함유하는 항쇼크제 (Pyridazinone Derivatives or their Salts, Processes for their Production, and Anti-Shock Agents Containing Them) | |
| RU96120159A (ru) | Производные тиазолидиндиона в качестве противогипергликемических средств | |
| KR870010043A (ko) | 헤테로고리로 치환된 벤즈이미다졸, 그의 제조방법 및 이들을 함유하는 제약조성물 | |
| ATE269862T1 (de) | Substituierte thiazolidinedione und oxazolidinedione mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften | |
| KR890002079A (ko) | 1-[2-(페닐메틸)페닐]피페라진 및 그의 제조방법 | |
| HUP0301561A2 (hu) | Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására |